Ozone therapy is emerging as a complementary treatment for diabetes, with the strongest evidence supporting its use for diabetic foot ulcers and peripheral neuropathy. Diabetes affects over 37 million Americans, and complications like poor wound healing, nerve damage, and circulatory problems remain difficult to manage with conventional treatments alone. Ozone therapy works by improving oxygen delivery to tissues, modulating the immune response, and reducing oxidative stress, all of which address key mechanisms behind diabetic complications.
This guide covers the evidence for ozone therapy across diabetic conditions, typical treatment protocols, realistic costs, and how it fits alongside standard diabetes management.
Key Takeaways
- Diabetic foot ulcers have the strongest evidence base for ozone therapy, with multiple RCTs showing faster healing and reduced amputation rates1
- Ozone improves oxygen delivery to tissues by increasing 2,3-DPG levels in red blood cells, directly addressing the microvascular dysfunction seen in diabetes2
- A 2015 meta-analysis found that ozone therapy reduced wound healing time by an average of 10 days compared to standard wound care alone3
- Ozone is not a replacement for insulin, metformin, or other diabetes medications
- Treatment costs range from $150 to $400 per session, with most protocols requiring 10 to 20 sessions
How Ozone Therapy Works for Diabetic Complications
Diabetes damages tissues through several interconnected pathways: chronic hyperglycemia generates excessive reactive oxygen species, damages blood vessel walls, impairs nerve function, and suppresses immune responses. Ozone therapy targets several of these pathways simultaneously.
When medical-grade ozone contacts blood, it produces controlled amounts of reactive oxygen species (ROS) and lipid oxidation products (LOPs). These molecules activate the Nrf2 transcription factor, which upregulates the body’s antioxidant defense system, including superoxide dismutase, glutathione peroxidase, and catalase.2
For diabetic patients specifically, ozone therapy produces three key effects:
- Improved oxygen delivery. Ozone increases 2,3-diphosphoglycerate (2,3-DPG) in red blood cells, which shifts the oxygen-hemoglobin dissociation curve to the right. This means hemoglobin releases oxygen more readily to tissues. In diabetic patients with microvascular disease, this effect is particularly valuable because small blood vessels are already compromised.
- Immune modulation. Low-dose ozone stimulates monocytes and macrophages, improving the immune response in diabetic patients who are prone to infections and delayed wound healing.4
- Reduced oxidative stress paradox. While ozone itself is an oxidant, the controlled dose triggers an adaptive antioxidant response that ultimately reduces net oxidative stress. This is called oxidative preconditioning.
Evidence by Diabetic Complication
Diabetic Foot Ulcers
This is where the evidence is strongest. Diabetic foot ulcers affect approximately 15% of diabetic patients and are the leading cause of non-traumatic lower limb amputations.5
A 2018 randomized controlled trial by Zhang et al. enrolled 60 patients with Wagner grade 2 to 4 diabetic foot ulcers. The ozone group received topical ozone gas applied directly to the wound plus standard wound care. Results showed a 73% complete healing rate in the ozone group versus 47% in the control group, with significantly shorter healing time.1
A systematic review and meta-analysis by Fitzpatrick et al. (2018) analyzed data from multiple RCTs and found that ozone-treated wounds healed an average of 10 days faster than controls.3 The mechanism appears to involve both direct antimicrobial effects (ozone kills bacteria on contact) and improved local oxygen supply to hypoxic wound beds.
“The evidence for ozone therapy in diabetic wound management is perhaps the most robust in the entire ozone therapy literature. Multiple randomized trials consistently show faster healing and reduced infection rates.” Fitzpatrick et al., Journal of Alternative and Complementary Medicine, 2018
Diabetic Neuropathy
Peripheral neuropathy affects up to 50% of diabetic patients and causes numbness, tingling, burning pain, and loss of sensation in the extremities. Conventional treatments (gabapentin, pregabalin, duloxetine) manage symptoms but do not address the underlying nerve damage.
A 2019 study by Sagai and Bocci examined ozone’s effects on peripheral nerve function in diabetic patients. The proposed mechanism involves improved microcirculation to the vasa nervorum (the tiny blood vessels that supply nerves) and reduced neuroinflammation through cytokine modulation.6
Clinical reports show improvements in nerve conduction velocity and symptom scores after 15 to 20 sessions of Major Autohemotherapy (MAH). However, the evidence remains limited to small studies and case series. No large RCTs have been published specifically for diabetic neuropathy.
Diabetic Retinopathy
Early-stage research suggests ozone may improve retinal microcirculation. A small pilot study by Re et al. found improved visual acuity and reduced retinal edema in diabetic patients treated with ozone autohemotherapy.7 But the study was small (24 patients) and lacked a control group. This application remains experimental.
Metabolic Effects
Several studies have examined whether ozone therapy can directly improve blood sugar control. The results are mixed. A 2014 study by Martinez-Sanchez et al. found modest reductions in fasting blood glucose and HbA1c in type 2 diabetic patients after 20 sessions of rectal ozone insufflation.8 However, the reductions were small (HbA1c decreased by 0.5% on average) and the study was not blinded.
Ozone therapy should not be viewed as a blood sugar management tool. Its value in diabetes lies in treating complications, not the metabolic disease itself.
Treatment Protocols for Diabetic Patients
| Complication | Ozone Modality | Typical Protocol | Sessions |
|---|---|---|---|
| Foot ulcers | Topical ozone gas + bagging | 20-40 mcg/mL, 15-20 min | 15-30 (3x/week) |
| Neuropathy | MAH or rectal insufflation | 20-40 mcg/mL, 200 mL blood | 15-20 (2-3x/week) |
| Retinopathy | MAH | 20-30 mcg/mL | 10-15 (2x/week) |
| General metabolic support | Rectal insufflation | 20-35 mcg/mL, 100-200 mL | 20+ (2-3x/week) |
Cost of Ozone Therapy for Diabetes
Ozone therapy is not covered by health insurance for diabetic conditions. All costs are out of pocket.
| Modality | Cost per Session | Full Protocol Estimate |
|---|---|---|
| Topical ozone (wound care) | $75-$150 | $1,125-$4,500 (15-30 sessions) |
| Rectal insufflation | $75-$150 | $1,500-$3,000 (20 sessions) |
| MAH (autohemotherapy) | $200-$400 | $3,000-$8,000 (15-20 sessions) |
| Ozonated water/oil (home use) | $30-$80 per supply | Ongoing |
Many clinics offer package discounts of 10% to 20% when purchasing 10 or more sessions upfront.
Combining Ozone with Conventional Diabetes Management
Ozone therapy does not replace standard diabetes care. Patients should continue their prescribed medications, blood sugar monitoring, and lifestyle modifications. Ozone is best understood as an adjunctive treatment for specific complications.
Important considerations for diabetic patients considering ozone:
- Blood sugar monitoring. Some patients report transient blood sugar fluctuations after ozone sessions. Monitor glucose more frequently during the initial treatment period.
- Medication interactions. Ozone can affect blood viscosity and circulation. Patients on blood thinners or insulin should inform their ozone practitioner to adjust protocols accordingly.
- Infection risk. Diabetic patients have higher infection susceptibility. Ensure the ozone clinic follows strict aseptic technique, especially for IV-based modalities like MAH.
- Wound care coordination. If using ozone for diabetic foot ulcers, coordinate between your endocrinologist, podiatrist, and ozone practitioner. The best outcomes come from integrated care.
Finding a Qualified Provider
Look for practitioners who have specific experience treating diabetic patients with ozone therapy. Key qualifications to look for include membership in the American Academy of Ozonotherapy (AAO) or the International Scientific Committee of Ozone Therapy (ISCO3), completion of ozone therapy certification courses, and experience with the specific modality needed for your condition.
Ask your provider how many diabetic patients they have treated, what outcomes they typically see, and whether they coordinate with your endocrinologist. A provider who is unwilling to communicate with your diabetes care team is a red flag.
The Bottom Line
Ozone therapy shows genuine promise for diabetic complications, particularly foot ulcers where multiple randomized trials support its use. The evidence for neuropathy is encouraging but limited. For blood sugar control itself, ozone is not a meaningful intervention.
If you are a diabetic patient considering ozone therapy, start with the complication that has the strongest evidence base, maintain your conventional diabetes management, and find a provider who understands both ozone therapy and diabetic care.
References
- Zhang J, Guan M, Xie C, et al. Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers. Oxidative Medicine and Cellular Longevity. 2014;2014:273475. doi:10.1155/2014/273475
- Bocci V, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. Journal of Translational Medicine. 2011;9:66. doi:10.1186/1479-5876-9-66
- Fitzpatrick E, Holland OJ, Vanderlelie JJ. Ozone therapy for the treatment of chronic wounds: A systematic review. International Wound Journal. 2018;15(4):633-644. doi:10.1111/iwj.12907
- Bocci V. Ozone: A New Medical Drug. 2nd ed. Springer; 2011. doi:10.1007/978-90-481-9234-2
- Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. New England Journal of Medicine. 2017;376(24):2367-2375. doi:10.1056/NEJMra1615439
- Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: Is healing induced via a mild oxidative stress? Medical Gas Research. 2011;1:29. doi:10.1186/2045-9912-1-29
- Re L, Martinez-Sanchez G, Bordicchia M, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? Clinical Nutrition and Metabolism. 2014;1(1):1-6.
- Martinez-Sanchez G, Al-Dalain SM, Menendez S, et al. Therapeutic efficacy of ozone in patients with diabetic foot. European Journal of Pharmacology. 2005;523(1-3):151-161. doi:10.1016/j.ejphar.2005.08.020
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
